Trials / Terminated
TerminatedNCT01701843
Cromoglicate in Mastocytosis
A Phase II Exploratory Study Evaluating the Efficacy of Topical Cromoglicate Solution Compared to Topical Solution Vehicle in the Treatment of Mastocytosis
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- LEO Pharma · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this exploratory study is to investigate the clinical efficacy of study drug (LP0074) in the treatment of Mastocytosis. The trial will be performed as a left/right comparison study in male/female subjects with mastocytosis, in a prospective, double-blinded, randomised, single centre setting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cromoglicate | Twice daily topical treatment for 14 days |
| DRUG | Placebo | Twice daily topical treatment for 14 days |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2013-02-01
- Completion
- 2013-02-01
- First posted
- 2012-10-05
- Last updated
- 2025-02-24
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01701843. Inclusion in this directory is not an endorsement.